Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease [Phase 2]
A phase 2 clinical trial evaluating the efficacy and safety of Astragalus membranaceus in mild-to-moderate Alzheimer's disease has completed…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Community-based Brain Health Program to Address Dementia Risk [NA]
Clinical trial update reports that a community-based brain health program designed to address dementia risk has completed the study. The pro…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type [Phase 2, Phase 3]
This document reports the completion and results posting of a Phase 2/3 clinical trial evaluating brexpiprazole for agitation in Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease [Phase 2]
A completed Phase 2 trial evaluated Flos Gossypii flavonoids tablet in Alzheimer's disease, assessing efficacy and safety. The trial was spo…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease [NA]
Clinical trial update reporting completion of the ADvance II study evaluating DBS-f in mild Alzheimer's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding [NA]
A completed clinical trial evaluating whether visual cues and education help residents in long-term care communities with wayfinding, with r…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: The Retain Your Brain Health Study (RetainYourBrain.com) [NA]
Completed status update for the Retain Your Brain Health Study (NCT06027320) sponsored by Retain Health, Inc., investigating Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology [Phase 2]
A Phase 2 study evaluating CY6463 in participants with Alzheimer's disease with vascular pathology has been terminated, and results were pos…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil [Phase 1]
A phase 1 study evaluating the safety and tolerability of ASP0777 in individuals with Alzheimer's disease who are taking a stable dose of do…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) [Phase 1]
Phase 1 Cognition Platform study of MK-0000-413 in participants at risk for Alzheimer's disease, with the trial completed and results posted…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: "Safety in Dementia": An Online Caregiver Intervention [NA]
A completed clinical trial from the University of Colorado Denver evaluating an online caregiver intervention for dementia-related safety an…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Repetitive TMS of the Posterior DMN in AD [NA]
A clinical trial evaluating repetitive transcranial magnetic stimulation targeting the posterior default mode network in Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants [Phase 1]
Phase 1 study comparing Sabirnetug IV and Sabirnetug with rHuPH20 SC in healthy participants to assess safety, tolerability, and pharmacokin…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia) [NA]
The CB3 Pilot trial evaluating a person-centered internet-based intervention for Primary Progressive Aphasia has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
The completed clinical trial evaluated florbetapir as a PET imaging agent in Primary Progressive Aphasia and related dementias, including Al…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Safety of a Strategy Combining Etanercept Administration with Repeated Contrast Ultrasound in Patients with Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial evaluating the safety of combining etanercept administration with repeated contrast-enhanced ultrasound in patients…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) [Phase 2]
Phase 2 clinical trial update reporting the efficacy and safety results of MK-1942 as an adjunct therapy in people with mild-to-moderate Alz…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Cerebellar ITBS Mode Transcranial Magnetic Stimulation for the Treatment of Alzheimer's Disease [NA]
Status update indicating that a clinical trial evaluating cerebellar ITBS mode transcranial magnetic stimulation for Alzheimer’s disease has…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) [Phase 2]
A Phase 2 study evaluating grape seed extract as an anti-oligomerization agent in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Recognizing Pain Intensity in Alzheimer's Disease [NA]
This clinical trial update indicates that the study on recognizing pain intensity in Alzheimer's disease has been terminated (Centre Hospita…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease [EARLY_Phase 1]
A Phase 1 trial investigating HP Xenon-129 fMRI in healthy volunteers and participants with Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Combined Effect of tDCS and Motor or Cognitive Activity in Patients With Alzheimer's Disease [NA]
The study evaluating the combined effect of transcranial direct current stimulation (tDCS) with motor or cognitive activity in Alzheimer dis…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of SAGE-718 in participants with mild cognitive impairment or mild dementia due to Al…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD [Phase 1]
A Phase 1 trial of LY3002813 in participants with memory impairment due to Alzheimer's disease has completed, with results posted on 2024-10…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Faith-Based Toolbox for African Americans With Dementia [NA]
The completed clinical trial evaluating a faith-based toolbox for African Americans with Alzheimer's disease and dementia has posted its res…